SCOR Se
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SZCRF research report →
Price Chart
About the company
SCOR SE is a prominent global player specializing in life and property & casualty (P&C) reinsurance. The company extends its comprehensive coverage to diverse markets spanning Europe, the Middle East, Africa, the Americas (including Latin America), and the Asia Pacific region. Its business is strategically organized into two distinct segments: SCOR Global P&C and SCOR Global Life.
- CEO
- Thierry Leger
- IPO
- 2012
- Employees
- 3,610
- HQ
- Paris, IF, FR
Get TickerSpark's AI analysis on SZCRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $6.83B
- P/E
- 7.70
- Fwd P/E
- 8.87
- PEG
- -1.11
- P/S
- 0.39
- P/B
- 1.45
- EV/EBITDA
- 6.03
- Div Yield
- 5.43%
- Gross Margin
- 20.41%
- Op Margin
- 7.18%
- Net Margin
- 5.13%
- ROE
- 18.37%
- ROIC
- 2.21%
Latest fiscal year · YoY change
- Revenue
- $14.80B-5.4%
- Gross Profit
- $13.96B-5.9%
- Op Income
- $1.18B
- Net Income
- $850.68M+21167.0%
- EPS
- $4.76+21245.3%
- OCF Growth
- +29.5%
- FCF Growth
- +29.1%
- 52W High
- $38.25
- 52W Low
- $30.41
- 50D MA
- $38.25
- 200D MA
- $36.82
- Beta
- 0.50
- RSI (14)
- 94
- Avg Volume
- 3
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
SCOR posted strong Q3 results with higher earnings, a 221% solvency ratio, and management saying it remains on track to finish Forward 2026 from a position of strength.· October 30, 2026
- Q3 group net income was EUR 206 million, implying a 20.4% ROE; 9M net income reached EUR 615 million, or a 19.3% annualized ROE.
- P&C remained very solid with an 84.1% combined ratio in Q3 and 81.3% for the first 9 months, while management said it is still building buffers.
- Life & Health continued to perform in line with expectations, with Q3 insurance service result of EUR 119 million and positive experience variance of EUR 12 million.
- Investment income stayed supportive, with a 4.1% regular income yield and a 3.7% return on invested assets; reinvestment rate was 5% at Sept. 30.
- Management said the market remains competitive, especially in P&C, but it expects to prioritize margin and quality over volume heading into 2027 renewals.
SCOR reported Q3 2026 group net income of EUR 206 million and a Q3 ROE of 20.4%. For the first 9 months, group net income was EUR 615 million, corresponding to an annualized ROE of 19.3%. P&C posted a Q3 combined ratio of 84.1% and a 9M combined ratio of 81.3%; the nat cat ratio was 9.1% in the quarter. P&C insurance revenue increased 2.3% at constant FX and 3.5% at current FX in Q3. Life & Health delivered a Q3 insurance service result of EUR 119 million, including EUR 12 million of positive experience variance. SCOR’s economic value was EUR 8.9 billion, up 11.9% at constant economics in 9M, and the solvency ratio reached 221%, up 6 percentage points versus year-end 2025. For guidance, management kept its solvency guidance at 10% to 15% for the Solvency II review impact and said it remains confident in achieving its targets under Forward 2026, while the new strategic plan will be presented on Dec. 3.
Thierry Leger described the quarter as a strong and clean set of results and emphasized that SCOR is entering the next strategic cycle from a much stronger position. He said the company will keep focusing on margin and quality over volume in a softening P&C market, while also highlighting opportunities in Life & Health and investments. He also said the impact from recent political unrest in France should be limited and manageable given SCOR’s diversification and conservative investment approach.
Philipp Ruede highlighted that all three businesses delivered strong results in Q3. He pointed to the 20.4% quarterly ROE, the 84.1% P&C combined ratio, the EUR 119 million Life & Health insurance service result, a 4.1% regular income yield, a 3.7% return on invested assets, and a 221% solvency ratio. He also said the nat cat ratio stayed within budget at 9.1%, that new business CSM in P&C was stable at EUR 1.12 billion over 9M, and that the balance sheet continues to strengthen thanks to strong capital generation.
Analysts focused on P&C attritional performance, buffer building, pricing pressure into 2027, and how to read the solvency ratio ahead of renewals. Management said it would not quantify quarterly buffer builds, but reiterated that it can still build buffers and that attritional performance reflects underwriting discipline, good price adequacy from 2025 and 2026 business, and a limited deterioration of about 2 points in combined ratio between 2025 and 2026. On pricing, management said treaty renewals are still early, but pressure is visible and property cat pricing in some European countries is down high single digit to low double digit. Questions also covered Life & Health cash flow and assumptions; management said cash flow is volatile quarter to quarter and that it expects to reach neutral or positive Life & Health cash flow in 2026, while Thierry Leger said the Life reset has now reached 7 of the 8 quarters he wanted before concluding the assumptions are sound.
The call showed broad-based momentum, with strong earnings, a high solvency ratio, and solid performance across P&C, Life & Health, and investments. Management sounded confident that Forward 2026 remains on track and that SCOR is now well positioned for its next strategic cycle, with Life & Health consistency and capital generation supporting that view.
Management repeatedly warned that P&C competition remains intense and that pricing is softening, especially in cat and other less loss-affected lines. They also flagged that future renewal outcomes will likely reflect continued price pressure, that buffer building is still needed, and that some revenue trends are being affected by EGPI revisions, retro timing, and exits from underperforming lines such as U.S. casualty and space.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.2%
- Shares Outstanding
- 178.67M
- Float Shares
- 168.33M
Held by 4 ETFs
Biggest fund positions in SZCRF by dollar value.
Our SZCRF coverage
Recent articles, reports, and earnings notes.
No research on SZCRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SZCRF report →Information regarding the redemption by SCOR SE of outstanding €282.9 million subordinated notes
globenewswire.com · Jun 8
SCOR SE (SCRYY) Q1 2026 Earnings Call Transcript
seekingalpha.com · May 6
SCOR SE announces the availability of its 2025 Universal Registration Document
globenewswire.com · Mar 13
SCOR SE (SCRYY) Q4 2025 Earnings Call Transcript
seekingalpha.com · Mar 4
SCOR SE (SCRYY) Shareholder/Analyst Call Transcript
seekingalpha.com · Feb 4
SCOR SE (SCRYY) Q3 2025 Earnings Call Transcript
seekingalpha.com · Oct 31
Information regarding the redemption by SCOR SE of outstanding €63.6 million undated subordinated notes
globenewswire.com · Oct 1
SCOR SE (SZCRF) Q2 2025 Earnings Call Transcript
seekingalpha.com · Aug 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.